MHRA Recalls Sertraline Batch Containing Citalopram

The Medicines and Healthcare products Regulatory Agency has issued an urgent recall for a specific batch of Sertraline 100mg film-coated tablets after a packaging error led to some packs containing Citalopram 40mg tablets instead. The recall, announced on April 28, affects products distributed across the United Kingdom and was prompted by a patient complaint.

The affected batch, numbered V2500425 and manufactured by Amarox Limited, involves cartons labeled as Sertraline 100mg that include one blister strip of Citalopram 40mg. Both medications are selective serotonin reuptake inhibitors, or SSRIs, prescribed for depression, anxiety disorders, and other mental health conditions. They work by increasing serotonin levels in the brain to help regulate mood. The mix-up occurred during the secondary packaging stage at the same facility, where blister strips were incorrectly placed into the cartons.

Patients who have received prescriptions for Sertraline 100mg are urged to check the batch number and expiry date on the side of the outer packaging. Dr. Alison Cave, MHRA chief safety officer, stated, "If you have been prescribed Sertraline 100mg tablets and have received batch number...